Enwei Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Enwei Pharmaceutical has a total shareholder equity of CN¥1.1B and total debt of CN¥34.3M, which brings its debt-to-equity ratio to 3.2%. Its total assets and total liabilities are CN¥1.4B and CN¥276.0M respectively. Enwei Pharmaceutical's EBIT is CN¥70.3M making its interest coverage ratio -18.8. It has cash and short-term investments of CN¥371.5M.
Key information
3.2%
Debt to equity ratio
CN¥34.28m
Debt
Interest coverage ratio | -18.8x |
Cash | CN¥371.53m |
Equity | CN¥1.08b |
Total liabilities | CN¥275.99m |
Total assets | CN¥1.36b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 301331's short term assets (CN¥796.4M) exceed its short term liabilities (CN¥219.2M).
Long Term Liabilities: 301331's short term assets (CN¥796.4M) exceed its long term liabilities (CN¥56.8M).
Debt to Equity History and Analysis
Debt Level: 301331 has more cash than its total debt.
Reducing Debt: 301331's debt to equity ratio has reduced from 5.5% to 3.2% over the past 5 years.
Debt Coverage: 301331's debt is well covered by operating cash flow (261.3%).
Interest Coverage: 301331 earns more interest than it pays, so coverage of interest payments is not a concern.